189 related articles for article (PubMed ID: 24720840)
21. Murine cytomegalovirus inactivated by sodium periodate is innocuous and immunogenic in mice and protects them against death and infection.
Geoffroy F; Moachon N; Rodwell J; Quash GA
Vaccine; 1996 Dec; 14(17-18):1686-94. PubMed ID: 9032900
[TBL] [Abstract][Full Text] [Related]
22. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
23. Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine.
Chang H; Li X; Teng Y; Liang Y; Peng B; Fang F; Chen Z
DNA Cell Biol; 2010 Sep; 29(9):563-8. PubMed ID: 20380570
[TBL] [Abstract][Full Text] [Related]
24. Antibody alone does not prevent experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency (MAIDS).
Dix RD; Cray C; Cousins SW
Ophthalmic Res; 1997; 29(6):381-92. PubMed ID: 9380340
[TBL] [Abstract][Full Text] [Related]
25. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features.
Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S
Front Immunol; 2021; 12():681380. PubMed ID: 34168650
[TBL] [Abstract][Full Text] [Related]
26. Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.
Karuturi BV; Tallapaka SB; Phillips JA; Sanderson SD; Vetro JA
Clin Immunol; 2015 Dec; 161(2):251-9. PubMed ID: 26111481
[TBL] [Abstract][Full Text] [Related]
27. A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.
Mohr CA; Arapovic J; Mühlbach H; Panzer M; Weyn A; Dölken L; Krmpotic A; Voehringer D; Ruzsics Z; Koszinowski U; Sacher T
J Virol; 2010 Aug; 84(15):7730-42. PubMed ID: 20463067
[TBL] [Abstract][Full Text] [Related]
28. gB co-immunization with GP96 enhances pulmonary-resident CD8 T cells and exerts a long-term defence against MCMV pneumonitis.
Guo B; Xu P; Chai D; Cao L; Liu L; Song T; Hu S; Chen Y; Yan X; Xu T
J Cell Mol Med; 2020 Dec; 24(24):14426-14440. PubMed ID: 33155438
[TBL] [Abstract][Full Text] [Related]
29. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
Slavuljica I; Busche A; Babić M; Mitrović M; Gašparović I; Cekinović D; Markova Car E; Pernjak Pugel E; Ciković A; Lisnić VJ; Britt WJ; Koszinowski U; Messerle M; Krmpotić A; Jonjić S
J Clin Invest; 2010 Dec; 120(12):4532-45. PubMed ID: 21099111
[TBL] [Abstract][Full Text] [Related]
30. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
31. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
Lobigs M; Pavy M; Hall RA; Lobigs P; Cooper P; Komiya T; Toriniwa H; Petrovsky N
J Gen Virol; 2010 Jun; 91(Pt 6):1407-17. PubMed ID: 20130134
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
Kumar M; Sudeep AB; Arankalle VA
Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
[TBL] [Abstract][Full Text] [Related]
33. Complete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gO.
Wang H; Huang C; Dong J; Yao Y; Xie Z; Liu X; Zhang W; Fang F; Chen Z
PLoS One; 2015; 10(3):e0119964. PubMed ID: 25803721
[TBL] [Abstract][Full Text] [Related]
34. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
35. Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein.
Gorman S; Lloyd ML; Smith LM; McWhorter AR; Lawson MA; Redwood AJ; Shellam GR
Vaccine; 2008 Jul; 26(31):3860-9. PubMed ID: 18573574
[TBL] [Abstract][Full Text] [Related]
36. Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses.
Wu CY; Chang CY; Ma HH; Wang CW; Chen YT; Hsiao PW; Chang CC; Chan CH; Liu CC; Chen JR
Vaccine; 2014 Jul; 32(35):4485-4494. PubMed ID: 24962757
[TBL] [Abstract][Full Text] [Related]
37. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
38. Single immunization with MF59-adjuvanted inactivated whole-virion H7N9 influenza vaccine provides early protection against H7N9 virus challenge in mice.
Chang H; Duan J; Zhou P; Su L; Zheng D; Zhang F; Fang F; Li X; Chen Z
Microbes Infect; 2017 Dec; 19(12):616-625. PubMed ID: 28899814
[TBL] [Abstract][Full Text] [Related]
39. Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus.
Noda S; Tanaka K; Sawamura S; Sasaki M; Matsumoto T; Mikami K; Aiba Y; Hasegawa H; Kawabe N; Koga Y
J Immunol; 2001 Mar; 166(5):3533-41. PubMed ID: 11207313
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.
Han HJ; Song MS; Park SJ; Byun HY; Robles NJC; Ha SH; Choi YK
J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
